These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24894840)

  • 1. Whole brain radiation therapy followed by intensity-modulated boosting treatment combined with concomitant temozolomide for brain metastases from non-small-cell lung cancer.
    Wang Q; Jiang Z; Qi X; Lu S; Wang S; Leng C; Lu F; Liu H; Liang S; Shi J
    Clin Transl Oncol; 2014 Nov; 16(11):1000-5. PubMed ID: 24894840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-brain radiation therapy plus concomitant temozolomide for the treatment of brain metastases from non-small-cell lung cancer: a randomized, open-label phase II study.
    Chua D; Krzakowski M; Chouaid C; Pallotta MG; Martinez JI; Gottfried M; Curran W; Throuvalas N
    Clin Lung Cancer; 2010 May; 11(3):176-81. PubMed ID: 20439193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320.
    Sperduto PW; Wang M; Robins HI; Schell MC; Werner-Wasik M; Komaki R; Souhami L; Buyyounouski MK; Khuntia D; Demas W; Shah SA; Nedzi LA; Perry G; Suh JH; Mehta MP
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1312-8. PubMed ID: 23391814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancer.
    Cao KI; Lebas N; Gerber S; Levy C; Le Scodan R; Bourgier C; Pierga JY; Gobillion A; Savignoni A; Kirova YM
    Ann Oncol; 2015 Jan; 26(1):89-94. PubMed ID: 25355723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases.
    Deng X; Zheng Z; Lin B; Su H; Chen H; Fei S; Fei Z; Zhao L; Jin X; Xie CY
    BMC Cancer; 2017 Jan; 17(1):42. PubMed ID: 28068937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases.
    Addeo R; De Rosa C; Faiola V; Leo L; Cennamo G; Montella L; Guarrasi R; Vincenzi B; Caraglia M; Del Prete S
    Cancer; 2008 Nov; 113(9):2524-31. PubMed ID: 18798231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole brain reirradiation and concurrent temozolomide in patients with brain metastases.
    Minniti G; Scaringi C; Lanzetta G; Bozzao A; Romano A; De Sanctis V; Valeriani M; Osti M; Enrici RM
    J Neurooncol; 2014 Jun; 118(2):329-334. PubMed ID: 24718862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole brain irradiation and temozolomide based chemotherapy in melanoma brain metastases.
    Conill C; Jorcano S; Domingo-Doménech J; Gallego R; Malvehy J; Puig S; Sánchez M; Vilella R; Castel T
    Clin Transl Oncol; 2006 Apr; 8(4):266-70. PubMed ID: 16648102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial.
    Verger E; Gil M; Yaya R; Viñolas N; Villà S; Pujol T; Quintó L; Graus F
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):185-91. PubMed ID: 15629610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of temozolomide and concomitant whole-brain radiotherapy in patients with brain metastases from solid tumors.
    Kouvaris JR; Miliadou A; Kouloulias VE; Kolokouris D; Balafouta MJ; Papacharalampous XN; Vlahos LJ
    Onkologie; 2007 Jul; 30(7):361-6. PubMed ID: 17596744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain metastases from melanoma: is there a role for concurrent temozolomide in addition to whole brain radiation therapy?
    Schild SE; Behl D; Markovic SN; Brown PD; Sande JR; Deming RL; Rowland KM; Bearden JD
    Am J Clin Oncol; 2010 Dec; 33(6):633-6. PubMed ID: 20042969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-brain irradiation with concomitant daily fixed-dose temozolomide for brain metastases treatment: a randomised phase II trial.
    Gamboa-Vignolle C; Ferrari-Carballo T; Arrieta Ó; Mohar A
    Radiother Oncol; 2012 Feb; 102(2):187-91. PubMed ID: 22257825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-brain radiotherapy plus sequential or simultaneous integrated boost for the treatment of a limited number of brain metastases in non-small cell lung cancer: A single-institution study.
    Qing D; Zhao B; Zhou YC; Zhu HL; Ma DY
    Cancer Med; 2020 Jan; 9(1):238-246. PubMed ID: 31749325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant treatment of brain metastasis with whole brain radiotherapy [WBRT] and temozolomide [TMZ] is active and improves quality of life.
    Addeo R; Caraglia M; Faiola V; Capasso E; Vincenzi B; Montella L; Guarrasi R; Caserta L; Del Prete S
    BMC Cancer; 2007 Jan; 7():18. PubMed ID: 17254350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of brain metastasis from non-small cell lung cancer with whole brain radiotherapy and Gefitinib in a Chinese population.
    Ma S; Xu Y; Deng Q; Yu X
    Lung Cancer; 2009 Aug; 65(2):198-203. PubMed ID: 19091441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The outcomes of concomitant radiation plus temozolomide followed by adjuvant temozolomide for newly diagnosed high grade gliomas: the preliminary results of single center prospective study.
    Shawky H; Abo Hamar AH; Galal S; Zakaria F; El-Shorbagy D
    J Egypt Natl Canc Inst; 2009 Jun; 21(2):107-19. PubMed ID: 21057562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of temozolomide combined with whole brain radiotherapy for non-small cell lung cancer brain metastases.
    Zhu Y; Fu L; Jing W; Guo D; Kong L; Yu J
    Thorac Cancer; 2018 Sep; 9(9):1121-1128. PubMed ID: 29947170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II Study of the Efficacy and Safety of High-dose Pemetrexed in Combination with Cisplatin
    He Q; Bi X; Ren C; Wang Y; Zou P; Zhang H; Chi N; Xiu C; Wang Y; Tao R
    Anticancer Res; 2017 Aug; 37(8):4711-4716. PubMed ID: 28739776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temozolomide added to whole brain radiotherapy in patients with multiple brain metastases of non-small-cell lung cancer: a multicentric Austrian phase II study.
    Hassler MR; Pfeifer W; Knocke-Abulesz TH; Geissler K; Altorjai G; Dieckmann K; Marosi C
    Wien Klin Wochenschr; 2013 Aug; 125(15-16):481-6. PubMed ID: 23907204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiochemotherapy with temozolomide for patients with glioblastoma. Prognostic factors and long-term outcome of unselected patients from a single institution.
    Gerstein J; Franz K; Steinbach JP; Seifert V; Rödel C; Weiss C
    Strahlenther Onkol; 2011 Nov; 187(11):722-8. PubMed ID: 22037649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.